top of page
Researcher

ENACT-SOS COVID

Start Date:

April 2020

End Date:

March 2022 

Duration:

12 months

ID-CARE Role:
Website:

Leader

Description

Title: Seroprevalence assessment of SARS-CoV2  infections amongst healthcare professionals working in the 4 main hospitals of the Verona province and in their cohabitants.


Primary objective: SARS-CoV-2 seroprevalence amongst health-care workers and their cohabitants.

Partners

University of Verona (Coordinator) 

ULSS9 Scaligera di Verona

Sponsor
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Publications

Diagnostics

14/11/22

High plasma levels of Activated Factor VII-Antithrombin Complex Point to increased Tissue Factor Expression in patients with SARS-CoV-2 pneumonia: a potential link with COVID-19 Prothrombotic Diathesis

Nature communications

4/3/21

Deciphering the state of immune silence in fatal COVID-19 patients

Epidemiology & Infection

31/1/22

COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence

Journal of Neurology, Neurosurgery & Psychiatry

31/8/20

Nervous system: subclinical target of SARS-CoV-2 infection

Infectious Diseases and Therapy

20/6/21

Long-term patient-centred follow-up in a prospective cohort of patients with COVID-19

ID-CARE Participants

Evelina Tacconelli

Director

Maddalena Cordioli

Medical Doctor

Elena Carrara

Clinical Researcher, MD

Massimo Mirandola

Epidemiologist

From our Blog
In the News
bottom of page